Inhibrx Biosciences, Inc. INBX Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s operating lease right-of-use assets in other assets?
- Inhibrx Biosciences, Inc. (INBX) reported operating lease right-of-use assets in other assets of $5.05M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Inhibrx Biosciences, Inc.'s operating lease right-of-use assets in other assets decreased by 26.8% year-over-year, from $6.9M to $5.05M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s operating lease right-of-use assets in other assets?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s operating lease right-of-use assets in other assets has grown at a 36.9% compound annual growth rate (CAGR), from $2.95M to $5.54M.